Zealand Pharma A/S
ZLDPF
$61.00
$3.506.09%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.61B | 1.24B | 1.14B | 1.27B | 1.28B |
| Total Receivables | 67.18M | 58.38M | 40.40M | 24.85M | 16.98M |
| Inventory | 1.62M | 1.55M | 1.49M | 120.10K | 115.40K |
| Prepaid Expenses | -- | -- | -- | 5.21M | 8.67M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | 5.32M | 5.11M |
| Total Current Assets | 2.68B | 1.30B | 1.18B | 1.30B | 1.31B |
|
|
|||||
| Total Current Assets | 2.68B | 1.30B | 1.18B | 1.30B | 1.31B |
| Net Property, Plant & Equipment | 21.12M | 18.78M | 17.39M | 19.28M | 21.02M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 2.14M | 2.05M | 1.75M | 1.73M | 1.72M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.74M | 2.95M | 2.83M | 3.71M | 1.81M |
| Total Assets | 2.70B | 1.32B | 1.32B | 1.44B | 1.46B |
|
|
|||||
| Total Accounts Payable | 49.16M | 35.40M | 25.17M | 34.35M | 32.66M |
| Total Accrued Expenses | -- | -- | 13.00M | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.75M | 2.38M | 2.23M | 2.38M | 4.29M |
| Total Finance Division Other Current Liabilities | 125.58M | 13.92M | 15.62M | -- | -- |
| Total Other Current Liabilities | 125.58M | 13.92M | 15.62M | -- | -- |
| Total Current Liabilities | 177.49M | 51.70M | 56.01M | 36.74M | 36.95M |
|
|
|||||
| Total Current Liabilities | 177.49M | 51.70M | 56.01M | 36.74M | 36.95M |
| Long-Term Debt | 46.28M | 41.99M | 39.61M | 42.03M | 39.77M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 13.45M | 12.81M | 12.55M | 13.84M | 11.98M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 10.14M | 11.40M | 15.22M | 19.07M | 20.43M |
| Total Liabilities | 247.37M | 117.90M | 123.39M | 111.68M | 109.12M |
|
|
|||||
| Common Stock & APIC | 2.33B | 2.14B | 2.05B | 2.21B | 2.12B |
| Retained Earnings | 126.45M | -937.43M | -854.79M | -881.14M | -772.34M |
| Treasury Stock & Other | 3.64M | 3.34M | 3.11M | 3.40M | 3.26M |
| Total Common Equity | 2.46B | 1.20B | 1.20B | 1.33B | 1.35B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 2.46B | 1.20B | 1.20B | 1.33B | 1.35B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 2.46B | 1.20B | 1.20B | 1.33B | 1.35B |
|
|
|||||